An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis
- PMID: 8283960
- DOI: 10.1007/BF00579623
An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis
Abstract
Earlier we reported that vaccination of leprosy patients with Mycobacterium w induces an immune response directed predominantly against low molecular weight antigens. One of these antigens, with a molecular mass of 30-kDa, was recognized by a majority of the vaccinated subjects as well as the tuberculoid leprosy patients and healthy contacts. In the present communication we report further characterization of this antigen. Immunofluorescence and Western blot studies with antibodies raised against this antigen demonstrate that it is associated with the cell surface and has homologues present in M. leprae and M. tuberculosis. Delayed-type hypersensitivity studies carried out in guinea pigs immunized with the 30-kDa antigen show that in addition to sharing B cell determinants, this immunodominant antigen of M. w also shares T cell determinants with M. leprae and M. tuberculosis.
Similar articles
-
Immuno-blot analysis of antigens of Mycobacterium w: a candidate anti-leprosy vaccine using monoclonal antibodies and patient sera.Zentralbl Bakteriol. 1990 Aug;273(3):378-85. doi: 10.1016/s0934-8840(11)80441-x. Zentralbl Bakteriol. 1990. PMID: 1698376
-
Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):265-73. Int J Lepr Other Mycobact Dis. 1988. PMID: 3045224
-
T-cell responses to fractionated antigens of Mycobacterium w, a candidate anti-leprosy vaccine, in leprosy patients.Scand J Immunol. 1991 Jul;34(1):23-31. doi: 10.1111/j.1365-3083.1991.tb01517.x. Scand J Immunol. 1991. PMID: 2068531
-
Leprosy and tuberculosis vaccine design.Trop Med Parasitol. 1989 Sep;40(3):251-7. Trop Med Parasitol. 1989. PMID: 2482532 Review.
-
M. leprae recombinant antigens important for T-cell reactivity.Indian J Lepr. 1999 Jan-Mar;71(1):75-86. Indian J Lepr. 1999. PMID: 10439328 Review.
Cited by
-
Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner.J Leukoc Biol. 2015 Mar;97(3):511-20. doi: 10.1189/jlb.1A0714-361R. Epub 2015 Jan 15. J Leukoc Biol. 2015. PMID: 25593326 Free PMC article.
-
Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner.Immunology. 2014 Oct;143(2):258-68. doi: 10.1111/imm.12306. Immunology. 2014. PMID: 24766519 Free PMC article.
-
Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.Infect Immun. 2009 Jan;77(1):223-31. doi: 10.1128/IAI.00526-08. Epub 2008 Nov 3. Infect Immun. 2009. PMID: 18981249 Free PMC article.
-
Mycobacterium w - a promising immunotherapeutic intervention for diseases.Front Immunol. 2024 Oct 29;15:1450118. doi: 10.3389/fimmu.2024.1450118. eCollection 2024. Front Immunol. 2024. PMID: 39534596 Free PMC article. Review.